Diagnostic Challenges in IC (and Male CPPS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00672087 |
Recruitment Status
:
Completed
First Posted
: May 6, 2008
Last Update Posted
: February 3, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Chronic Prostatitis With Chronic Pelvic Pain Syndrome Chronic Bacterial Prostatitis Asymptomatic Inflammatory Prostatitis Painful Bladder Syndrome Cystitis, Interstitial | Genetic: Genomic and proteomic biomarker discovery |
Study Type : | Observational |
Estimated Enrollment : | 1000 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Diagnostic Challenges in IC (and Male CPPS) |
Study Start Date : | September 2003 |
Actual Primary Completion Date : | June 2011 |
Actual Study Completion Date : | June 2011 |

Group/Cohort | Intervention/treatment |
---|---|
A
Chronic prostatitis/chronic pelvic pain syndrome patients
|
Genetic: Genomic and proteomic biomarker discovery
Discovery of novel biomarkers for CP/CPPS and PBS/IC using genomic and proteomic methods
|
B
Painful bladder syndrome/interstitial cystitis patients
|
Genetic: Genomic and proteomic biomarker discovery
Discovery of novel biomarkers for CP/CPPS and PBS/IC using genomic and proteomic methods
|
C
Asymptomatic controls
|
Genetic: Genomic and proteomic biomarker discovery
Discovery of novel biomarkers for CP/CPPS and PBS/IC using genomic and proteomic methods
|

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Participant has signed and dated the appropriate Informed Consent document.
- Participant must have had symptoms of discomfort or pain in the pelvic region for at least a three (3) month period within the last six (6) months.
Exclusion Criteria:
- Major structural/anatomical urinary tract abnormalities
- Underlying inborn conditions

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00672087
United States, Massachusetts | |
Beth Israel Deaconess Medical Center | |
Boston, Massachusetts, United States, 02215 |
Study Chair: | Jordan D Dimitrakoff, MD, PhD | Harvard Medical School, Boston, MA |
Publications of Results:
Other Publications:
Responsible Party: | Jordan Dimitrakoff, MD, PhD, Director of Urogynecology and Chronic Pelvic Pain Lab, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA |
ClinicalTrials.gov Identifier: | NCT00672087 History of Changes |
Other Study ID Numbers: |
2010P000229 NIH DK065990 |
First Posted: | May 6, 2008 Key Record Dates |
Last Update Posted: | February 3, 2017 |
Last Verified: | February 2014 |
Keywords provided by Beth Israel Deaconess Medical Center:
Chronic Prostatitis with Chronic Pelvic Pain Syndrome Chronic Bacterial Prostatitis Asymptomatic Inflammatory Prostatitis Painful Bladder Syndrome Cystitis, Interstitial |
Additional relevant MeSH terms:
Syndrome Pelvic Pain Cystitis Prostatitis Cystitis, Interstitial Chronic Disease Disease Pathologic Processes |
Pain Neurologic Manifestations Signs and Symptoms Urinary Bladder Diseases Urologic Diseases Prostatic Diseases Genital Diseases, Male Disease Attributes |